Paul Y. Song, Chief Executive Officer at NKGen Biotech, Inc. (NKGN), bought 41,699,450 shares at $0.13 ($5.4M) on 2025-05-05, disclosed to the SEC on 2025-05-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.13 | 20,849,725 | $2.7M | 50.0% |
| 2 | $0.13 | 20,849,725 | $2.7M | 50.0% |
| Total | $0.13 avg | 41,699,450 | $5.4M | 100% |
| Filing → |
| NKGN | BUY | 2023-11-28 | $701 | — | Filing → |
| NKGN | BUY | 2023-11-22 | $430 | — | Filing → |